Cardax Inc (CDXI) Inventory Turnover Ratio, from first quarter 2021 to first quarter 2020, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Cardax Inc   (CDXI)
 

Cardax Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cardax Inc 's inventory turnover ratio, the ratio that measures Cardax Inc 's ability to manage its supply chain, sequentially decreased to 0.17 in the first quarter 2021, which does not come as a surprise, as the Cardax Inc continue to experience headwinds, which also impact its supply chain. Cardax Inc 's average inventory processing period in the Mar 31 2021 quarter, has increased to 2147 days, from 2028 days, in the Dec 31 2020 quarter.

Within Healthcare sector 402 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the First Quarter 2021 compared to previous quarter at no. 1989.

CDXI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cardax Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDXI Inventory Turnover Ratio (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Inventory Growth -13.77 % -15.58 % -19.11 % -23.97 % -21.53 %
Y / Y Cost of Sales Growth -39.08 % -26.58 % -77.23 % 31.85 % -39.53 %
Inventory Turnover Ratio (TTM) 0.17 0.18 0.2 0.27 0.24
CDXI's Total Ranking # 1989 # 1989 # 1989 # 1989 # 1975
Average inventory processing period 2180 1978 1837 1363 1508
Seq. Inventory Growth -3.16 % -6.01 % -2.34 % -2.98 % -5.2 %
Seq. Cost of Sales Growth -42.5 % 142.58 % -29.21 % -38.3 % -30.71 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 143
Healthcare Sector # 403
Overall Market # 1989

Inventory Turnover Ratio Statistics
High Average Low
7.89 1.28 0.01
(Sep 30 2017)   (Mar 31 2015)



CDXI Company Profile >> Back to CDXI Efficiency Comparisons >> Compare CDXI Inventory Turnover Ratio to its Competitors

Financial Statements
Cardax Inc 's Inventories $ 1 Millions Visit CDXI's Balance sheet
Cardax Inc 's Cost of Revenues TTM $ 0 Millions Visit CDXI's Income Statement
What are CDXI's Sales? Visit CDXI's Sales by Segment

Other Inventory Turnover Ratios
Cardax Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CDXI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CDXI's Competitors
Inventory Turnover Ratio for CDXI's Suppliers
Inventory Turnover Ratio for CDXI's Customers

You may also want to know
CDXI's Sales Growth Rates CDXI's Pe Price to earnings ratio CDXI's Receivables Turnover Ratio CDXI's Stock Quote
CDXI's Net Income Growth Rates CDXI's Ps Price to Sales ratio CDXI's Sales per Employee CDXI's Asset Turnover Ratio
CDXI's Net Margin CDXI's Pb Price to Book ratio CDXI's Financial Strength Ratios CDXI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2021 Inventories at quarter ending Mar 31 2021
Invo Fertility Inc   0.48 $ 0.122  Millions$ 0  Millions
One World Products Inc   0.45 $ 0.112  Millions$ 0  Millions
Nabriva Therapeutics Plc  0.45 $ 0.820  Millions$ 2  Millions
Neurocrine Biosciences Inc   0.43 $ 10.900  Millions$ 25  Millions
Bioventus Inc   0.40 $ 22.222  Millions$ 55  Millions
Regeneron Pharmaceuticals Inc   0.39 $ 729.000  Millions$ 1,881  Millions
Rigel Pharmaceuticals Inc  0.34 $ 1.056  Millions$ 3  Millions
Orthopediatrics Corp  0.33 $ 17.041  Millions$ 52  Millions
Bionik Laboratories Corp   0.32 $ 0.270  Millions$ 1  Millions
Cannabis Global Inc.  0.32 $ 0.030  Millions$ 0  Millions
Emmaus Life Sciences Inc   0.30 $ 2.206  Millions$ 7  Millions
Adamas Pharmaceuticals Inc  0.27 $ 1.851  Millions$ 7  Millions
Advanced Biomedical Technologies Inc   0.25 $ 0.029  Millions$ 0  Millions
Evofem Biosciences Inc   0.19 $ 0.974  Millions$ 5  Millions
Jrsis Health Care Corp  0.18 $ 0.274  Millions$ 2  Millions
Natus Medical Inc  0.17 $ 13.324  Millions$ 77  Millions
Cardax Inc   0.17 $ 0.172  Millions$ 1  Millions
Igc Pharma Inc   0.14 $ 0.785  Millions$ 6  Millions
Streamex Corp   0.13 $ 0.099  Millions$ 1  Millions
Stimcell Energetics Inc   0.13 $ 0.007  Millions$ 0  Millions
Cytodyn inc   0.11 $ 5.311  Millions$ 48  Millions
Deciphera Pharmaceuticals Inc   0.10 $ 0.447  Millions$ 5  Millions
Motus Gi Holdings Inc   0.09 $ 0.093  Millions$ 1  Millions
Rapid Therapeutic Science Laboratories Inc   0.08 $ 0.012  Millions$ 0  Millions
Ptc Therapeutics inc   0.08 $ 1.400  Millions$ 18  Millions
Global Blood Therapeutics Inc.  0.07 $ 2.435  Millions$ 36  Millions
Blueprint Medicines Corporation  0.06 $ 0.503  Millions$ 9  Millions
Guided Therapeutics Inc   0.05 $ 0.018  Millions$ 0  Millions

Date modified: 2026-09-08T15:10:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.